Andexanet alfa

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Andexanet alfa and local guidelines before prescribing.

Specific reversal agent

Mechanism

Recombinant factor Xa decoy binding anti-Xa inhibitors.

Uses

Reversal of apixaban or rivaroxaban in life-threatening bleeding.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Thromboembolic events, infusion reactions.

Interactions

Specific to factor Xa inhibitors.

Contraindications and cautions

None specific

Monitoring

Bleeding, thrombosis

Pregnancy and breastfeeding

Use if life-threatening

Renal and hepatic impairment

No adjustment

Overdose and reversal

Not applicable

Special advice

Thrombosis risk; availability limited; prothrombin complex concentrate an alternative.

More from the textbook: uses, cautions and other points
Where it is discussed in the book